1. Home
  2. CHR vs UNCY Comparison

CHR vs UNCY Comparison

Compare CHR & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

HOLD

Current Price

$1.59

Market Cap

130.4M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.15

Market Cap

126.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHR
UNCY
Founded
2016
2016
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.4M
126.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CHR
UNCY
Price
$1.59
$6.15
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$44.50
AVG Volume (30 Days)
387.8K
357.9K
Earning Date
07-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
96.06
N/A
Revenue
$147,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$3.71
52 Week High
$141.71
$11.00

Technical Indicators

Market Signals
Indicator
CHR
UNCY
Relative Strength Index (RSI) 79.11 56.66
Support Level $1.30 $5.36
Resistance Level $1.65 $5.95
Average True Range (ATR) 0.15 0.35
MACD 0.05 0.01
Stochastic Oscillator 94.08 80.30

Price Performance

Historical Comparison
CHR
UNCY

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: